Three Stumbling Blocks That New Clinical Research Sites Shouldn't Worry About

New sites don't have to worry about specializing during their early stages of development. The first priority will be to get the first few studies in order to give the PI research experience. Some sites worry about IRB restrictions but such concerns are often unfounded because sponsors provide a centralized IRB for the research site.

Comment